{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:34:01Z","timestamp":1791196441171,"version":"4.1.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["painjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.pain.2014.06.004","type":"journal-article","created":{"date-parts":[[2014,6,16]],"date-time":"2014-06-16T14:32:08Z","timestamp":1402929128000},"page":"1793-1801","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Long-term safety and effectiveness of tanezumab as treatment for chronic low back pain"],"prefix":"10.1097","volume":"155","author":[{"given":"Joseph S.","family":"Gimbel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J.","family":"Kivitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candace","family":"Bramson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Anne","family":"Nemeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine R.","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth M.","family":"Verburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210126","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1110\/ps.035402.108","article-title":"Probing the binding mechanism and affinity of tanezumab, a recombinant humanized anti-NGF monoclonal antibody, using a repertoire of biosensors.","volume":"17","author":"Abdiche","year":"2008","journal-title":"Protein Sci"},{"key":"R3-15-20210126","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1136\/bmj.38273.626655.63","article-title":"Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials.","volume":"329","author":"Bjordal","year":"2004","journal-title":"BMJ"},{"key":"R4-15-20210126","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jpain.2012.05.006","article-title":"Tanezumab reduces osteoarthritic knee pain: results of a randomized, double-blind, placebo-controlled phase 3 trial.","volume":"13","author":"Brown","year":"2012","journal-title":"J Pain"},{"key":"R5-15-20210126","doi-asserted-by":"crossref","first-page":"505","DOI":"10.7326\/0003-4819-147-7-200710020-00008","article-title":"Medications for acute and chronic low back pain: a review of the evidence for an American Pain SocietyAmerican College of Physicians clinical practice guideline.","volume":"147","author":"Chou","year":"2007","journal-title":"Ann Intern Med"},{"key":"R6-15-20210126","doi-asserted-by":"crossref","first-page":"492","DOI":"10.7326\/0003-4819-147-7-200710020-00007","article-title":"Nonpharmacologic therapies for acute and chronic low back pain: a review of the evidence for an American Pain SocietyAmerican College of Physicians clinical practice guideline.","volume":"147","author":"Chou","year":"2007","journal-title":"Ann Intern Med"},{"key":"R7-15-20210126","doi-asserted-by":"crossref","first-page":"478","DOI":"10.7326\/0003-4819-147-7-200710020-00006","article-title":"Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society.","volume":"147","author":"Chou","year":"2007","journal-title":"Ann Intern Med"},{"key":"R8-15-20210126","first-page":"129","article-title":"Pain assessment: global use of the Brief Pain Inventory.","volume":"23","author":"Cleeland","year":"1994","journal-title":"Ann Acad Med Singapore"},{"key":"R9-15-20210126","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJM200102013440508","article-title":"Low back pain.","volume":"344","author":"Deyo","year":"2001","journal-title":"N Engl J Med"},{"key":"R10-15-20210126","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1212\/WNL.45.6.1115","article-title":"Variables influencing neuropathic endpoints: the Rochester Diabetic Neuropathy Study of Healthy Subjects.","volume":"45","author":"Dyck","year":"1995","journal-title":"Neurology"},{"key":"R12-15-20210126","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.juro.2010.12.088","article-title":"Proof of concept trial of tanezumab for the treatment of symptoms associated with interstitial cystitis.","volume":"185","author":"Evans","year":"2011","journal-title":"J Urol"},{"key":"R15-15-20210126","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.tips.2005.12.001","article-title":"Novel class of pain drugs based on antagonism of NGF.","volume":"27","author":"Hefti","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"R16-15-20210126","first-page":"S113","article-title":"Adjudication of reported serious adverse joint events in the tanezumab clinical development program.","volume":"64","author":"Hochberg","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R17-15-20210126","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1016\/j.pain.2011.05.003","article-title":"Efficacy and safety of tanezumab in the treatment of chronic low back pain.","volume":"152","author":"Katz","year":"2011","journal-title":"PAIN"},{"key":"R18-15-20210126","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.pain.2013.03.006","article-title":"Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain.","volume":"154","author":"Kivitz","year":"2013","journal-title":"PAIN"},{"key":"R19-15-20210126","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1359\/jbmr.070711","article-title":"Effects of a monoclonal antibody raised against nerve growth factor on skeletal pain and bone healing after fracture of the C57BL6J mouse femur.","volume":"22","author":"Koewler","year":"2007","journal-title":"J Bone Miner Res"},{"key":"R20-15-20210126","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa0901510","article-title":"Tanezumab for treatment of knee osteoarthritis pain.","volume":"363","author":"Lane","year":"2010","journal-title":"N Engl J Med"},{"key":"R21-15-20210126","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/ALN.0b013e31821b1ac5","article-title":"Antagonism of nerve growth factor-TrkA signaling and the relief of pain.","volume":"115","author":"Mantyh","year":"2011","journal-title":"Anesthesiology"},{"key":"R22-15-20210126","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.joca.2011.09.006","article-title":"Preliminary assessment of the safety and efficacy of tanezumab in Japanese patients with moderate to severe osteoarthritis of the knee: a randomized, double-blind, dose-escalation, placebo-controlled study.","volume":"19","author":"Nagashima","year":"2011","journal-title":"Osteoarthritis Cartilage"},{"key":"R23-15-20210126","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.urology.2012.07.035","article-title":"Preliminary assessment of safety and efficacy in proof-of-concept, randomized clinical trial of tanezumab for chronic prostatitischronic pelvic pain syndrome.","volume":"80","author":"Nickel","year":"2012","journal-title":"Urology"},{"key":"R25-15-20210126","first-page":"S1","article-title":"Scientific approach to the assessment and management of activity-related spinal disorders. A monograph for clinicians. Report of the Quebec Task Force on Spinal Disorders.","volume":"12","year":"1987","journal-title":"Spine (Phila Pa 1)"},{"key":"R26-15-20210126","first-page":"1766","article-title":"Nonsteroidal anti-inflammatory drugs for low back pain: an updated Cochrane review. Spine (Phila Pa 1976).","volume":"33","author":"Roelofs","year":"2008","journal-title":""},{"key":"R27-15-20210126","first-page":"145","article-title":"A study of the natural history of low-back pain. Part II: development of guidelines for trials of treatment in primary care. Spine (Phila Pa 1976).","volume":"8","author":"Roland","year":"1983","journal-title":""},{"key":"R28-15-20210126","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0304-3959(01)00371-2","article-title":"What is a clinically meaningful reduction in pain?.","volume":"94","author":"Rowbotham","year":"2001","journal-title":"PAIN"},{"key":"R29-15-20210126","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ejpain.2003.09.004","article-title":"Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale.","volume":"8","author":"Salaffi","year":"2004","journal-title":"Eur J Pain"},{"key":"R30-15-20210126","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.joca.2011.01.009","article-title":"Long-term open-label study of tanezumab for moderate to severe osteoarthritic knee pain.","volume":"19","author":"Schnitzer","year":"2011","journal-title":"Osteoarthritis Cartilage"},{"key":"R31-15-20210126","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pain.2005.03.039","article-title":"Nerve growth factor mediates hyperalgesia and cachexia in auto-immune arthritis.","volume":"116","author":"Shelton","year":"2005","journal-title":"PAIN"},{"key":"R32-15-20210126","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/rheumatology\/keh121","article-title":"Celecoxib 200 mg q.d. is efficacious in the management of osteoarthritis of the knee or hip regardless of the time of dosing.","volume":"43","author":"Stengaard-Pedersen","year":"2004","journal-title":"Rheumatology"},{"key":"R33-15-20210126","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2165\/0063030-200822060-00002","article-title":"Targeting nerve growth factor in pain: what is the therapeutic potential?.","volume":"22","author":"Watson","year":"2008","journal-title":"BioDrugs"},{"key":"R34-15-20210126","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jpain.2004.02.538","article-title":"Effect of blockade of nerve growth factor and tumor necrosis factor on pain behaviors after plantar incision.","volume":"5","author":"Zahn","year":"2004","journal-title":"J Pain"}],"container-title":["Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006396-201409000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:44:41Z","timestamp":1785858281000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006396-201409000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1016\/j.pain.2014.06.004","relation":{},"ISSN":["0304-3959"],"issn-type":[{"value":"0304-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term safety and effectiveness of tanezumab as treatment for chronic low back pain","name":"articletitle","label":"Article Title"},{"value":"PAIN\u00ae","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.pain.2014.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}